Groundbreaking Pig Lung Transplant in China
In a remarkable medical achievement, a man in China has received a pig lung, marking a significant milestone in xenotransplantation. This historic procedure took place at the First Affiliated Hospital of Guangzhou Medical University, and the details were shared in an August report by the journal Nature.
The 39-year-old patient, who was declared brain-dead after a cerebral hemorrhage, received the genetically modified pig lung. Surprisingly, the organ showed resilience, functioning for nine days after the transplant.
The lung was derived from a pig that had undergone six genetic modifications by Chengdu Clonorgan Biotechnology, a research firm in China. This operation is part of a broader exploration of using animal organs in humans, and similar trials for pig livers and kidneys have recently been approved in the United States.
Researchers were keen to learn how well the pig lung would respond to the human immune system, particularly concerning potential rejection. During the initial 216 hours of monitoring, no signs of infection or rejection were found, a promising indicator for future transplants.
While some swelling and tissue damage were noted within the first 24 hours post-surgery, the damage caused by antibodies attacking the lung lessened by day nine. However, the study was concluded at the family’s request after nine days, highlighting ongoing concerns about organ rejection and infection.
Dr. Muhammad Mohiuddin, a prominent surgeon and researcher at the University of Maryland, emphasized the challenges of lung transplants, noting that lungs are particularly vulnerable to immune system attacks. He praised the effort of the Chinese researchers, calling it a valuable first step toward the future of lung xenotransplantation.
Despite this progress, further research is needed to fully understand the long-term viability of such transplants in humans.
